Navigating cell therapy supply chain complexities during the COVID-19 pandemic
Cell & Gene Therapy Insights 2020; 6(11), 1571.
10.18609/cgti.2020.173
Published: 16 December 2020
FastFacts
Watch the video or read the poster to learn:
- Why COVID-19 is disrupting time-sensitive supply chains for the cell therapy industry
- How Be The Match BioTherapies is addressing these challenges to deliver over 130 cell product shipments in a typical week